Gene · 51684
Papers2,311
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,311
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD56 polysialylation promotes the tumorigenesis and progression via the Hedgehog and Wnt/β-catenin signaling pathways in clear cell renal cell carcinoma. | Cancer Cell Int | 2023 | 38087309 | PubTator, text mining | PubMed |
| Paralog-specific TTC30 regulation of Sonic hedgehog signaling. | Front Mol Biosci | 2023 | 38074101 | PubTator, text mining | PubMed |
| Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy. | MedComm (2020) | 2023 | 38045829 | PubTator, text mining | PubMed |
| TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma. | J Transl Med | 2023 | 38037073 | PubTator, text mining | PubMed |
| Hedgehog signaling and the glioma-associated oncogene in cancer radioresistance. | Front Cell Dev Biol | 2023 | 38020914 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| RCC2 promotes prostate cancer cell proliferation and migration through Hh/GLI1 signaling pathway and cancer stem-like cells. | Biol Direct | 2023 | 38008751 | PubTator, text mining | PubMed |
| The Effects of Deregulated Ribosomal Biogenesis in Cancer. | Biomolecules | 2023 | 38002277 | PubTator, text mining | PubMed |
| Supraorbital Basosquamous Carcinoma Treated with Cemiplimab Followed by Sonidegib: A Case Report and Review of the Literature. | Biomedicines | 2023 | 38001904 | PubTator, text mining | PubMed |
| Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis. | Cancers (Basel) | 2023 | 38001599 | PubTator, text mining | PubMed |
| Clinical and Molecular Features of Morpheaform Basal Cell Carcinoma: A Systematic Review. | Curr Oncol | 2023 | 37999140 | PubTator, text mining | PubMed |
| A novel mutation of the RPGRIP1L gene in a Chinese boy with Joubert syndrome with oculorenal involvement. | BMC Pediatr | 2023 | 37993833 | PubTator, text mining | PubMed |
| The immunoreactivity of GLI1 and VEGFA is a potential prognostic factor in kidney renal clear cell carcinoma. | BMC Cancer | 2023 | 37964226 | PubTator, text mining | PubMed |
| Targeting hedgehog-driven mechanisms of drug-resistant cancers. | Front Mol Biosci | 2023 | 37954979 | PubTator, text mining | PubMed |
| Signaling Pathways and Therapeutic Strategies in Advanced Basal Cell Carcinoma. | Cells | 2023 | 37947611 | PubTator, text mining | PubMed |
| Nonsense-Mutation in SUFU ist mit multiplen infundibulozystischen Basalzellkarzinomen assoziiert: A nonsense mutation in SUFU associated with multiple infundibulocystic basal cell carcinomas. | J Dtsch Dermatol Ges | 2023 | 37946635 | PubTator, text mining | PubMed |
| Recent Advances in Pediatric Medulloblastoma. | Curr Neurol Neurosci Rep | 2023 | 37943476 | PubTator, text mining | PubMed |
| Brain Tumor Classification by Methylation Profile. | J Korean Med Sci | 2023 | 37935168 | PubTator, text mining | PubMed |
| Bilateral ovarian fibromas as the sole manifestation of Gorlin syndrome in a 22-year-old woman: a case report and literature review. | Diagn Pathol | 2023 | 37907964 | PubTator, text mining | PubMed |
| EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma. | Int J Mol Sci | 2023 | 37894854 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51684/papers?page=8